Working at Iovance Biotherapeutics - Glassdoor

Glassdoor gives you an inside look at what it's like to work at Iovance Biotherapeutics, including salaries, reviews, office photos, and more. This is the Iovance Biotherapeutics company …

CouponFollow Extension

37%
OFF

Iovance Biotherapeutics Reviews: What Is It Like To Work At

3 weeks from now

Iovance Biotherapeutics has an overall rating of 3.0 out of 5, based on over 104 reviews left anonymously by employees. 37% of employees would recommend working at Iovance …

glassdoor.com

2%
OFF

Iovance Biotherapeutics Reviews In Philadelphia | Glassdoor

3 weeks from now

Employees in Philadelphia have rated Iovance Biotherapeutics with 3.0 out of 5 for work-life-balance (18.2% higher than company-wide rating), 4.2 out of 5 for diversity and inclusion …

glassdoor.com

37%
OFF

Iovance Biotherapeutics Reviews - Glassdoor

3 weeks from now

Iovance Biotherapeutics has an overall rating of 3.0 out of 5, based on over 103 reviews left anonymously by employees. 37% of employees would recommend working at Iovance …

glassdoor.co.in

38%
OFF

Iovance Biotherapeutics "pay" Reviews | Glassdoor

3 weeks from now

Iovance Biotherapeutics has an overall rating of 3.2 out of 5, based on over 97 reviews left anonymously by employees. 38% of employees would recommend working at Iovance …

glassdoor.com

80%
OFF

What's Wrong With Iovance Biotherapeutics Stock?

3 weeks from now

Jan 30, 2025 · It was about a year ago that shares of Iovance Biotherapeutics (IOVA-5.80%) began to take off. The stock soared on news of approval from the Food and Drug …

fool.com

40%
OFF

Iovance Biotherapeutics Interview Questions (2025) - Glassdoor

3 weeks from now

Jan 7, 2025 · Glassdoor users rated their interview experience at Iovance Biotherapeutics as 40% positive with a difficulty rating score of 2.53 out of 5 (where 5 is the highest level of difficulty). …

glassdoor.com

FAQs about Working at Iovance Biotherapeutics - Glassdoor Coupon?

Should you buy iovance Biotherapeutics (iovance)?

If you're willing to take on some risk and can be patient with the stock, Iovance may be worth buying as it has the potential to generate some great returns given its modest valuation. David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Iovance Biotherapeutics. ...

How much cash does iovance have?

That's a problem because Iovance only reported $397.5 million in cash, cash equivalents, and investments as of the end of September. That's not a huge amount of liquid assets, especially given that it may need a lot more cash to grow its business in the months ahead. ...

Is iovance a good stock to buy?

Since hitting a high of more than $18 last February, however, the stock has been declining steadily. And over the past six months, it has fallen by 32%. Entering trading this week, shares of Iovance are worth a little over $6 -- just a fraction of the highs they reached when regulators approved Amtagvi. ...

How much money has iovance burned through?

Over the course of Iovance's past three quarters, the company has burned through a total of $279.7 million. This is before factoring in capital expenditures and only looks at its day-to-day operating activities. That's a problem because Iovance only reported $397.5 million in cash, cash equivalents, and investments as of the end of September. ...

Does iovance have a lack of profitability?

And a lack of a profitability isn't the only problem for investors, as they may need to brace for more dilution ahead. Over the course of Iovance's past three quarters, the company has burned through a total of $279.7 million. This is before factoring in capital expenditures and only looks at its day-to-day operating activities. ...